Ilaria Cangini

Meldola, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA.

Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA.

Journal: Scientific reports

Published: December 05, 2024

Comprehensive genetic and epigenetic characterization of Lynch-like syndrome patients.

Comprehensive genetic and epigenetic characterization of Lynch-like syndrome patients.

Journal: International journal of cancer

Published: October 28, 2024

Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial.

Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial.

Journal: ESMO open

Published: September 11, 2024

Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants.

Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants.

Journal: The oncologist

Published: April 12, 2024

A Novel FLCN Variant in a Suspected Birt-Hogg-Dubè Syndrome Patient.

A Novel FLCN Variant in a Suspected Birt-Hogg-Dubè Syndrome Patient.

Journal: International journal of molecular sciences

Published: July 13, 2023

Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.

Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.

Journal: Frontiers in oncology

Published: May 11, 2023

Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area.

Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area.

Journal: Cancers

Published: March 07, 2023

Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.

Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.

Journal: International journal of molecular sciences

Published: October 18, 2022

Case Report: A BRCA2 Mutation Identified Through Next-Generation Sequencing in a Birt-Hogg-Dubè Syndrome Family.

Case Report: A BRCA2 Mutation Identified Through Next-Generation Sequencing in a Birt-Hogg-Dubè Syndrome Family.

Journal: Frontiers in oncology

Published: December 14, 2021

Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer.

Comprehensive analysis of DNA damage repair genes reveals pathogenic variants beyond BRCA and suggests the need for extensive genetic testing in pancreatic cancer.

Journal: BMC cancer

Published: January 13, 2021

Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients.

Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients.

Journal: Diagnostics (Basel, Switzerland)

Published: March 31, 2020

Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome.

Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome.

Journal: International journal of colorectal disease

Published: September 23, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026